Selective serotonin reuptake inhibitors Drugs related to tricyclic antidepressants are a mixed bag
BMJPublished 22 October 1994Open access
Philip J. Cowen, Christopher M. Thompson
Citations4
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Compared with selective serotonin reuptake inhibitors, “newer tricyclic and related antidepresants … will have similar impact on rates of suicide but at considerably less cost”.
Keywords
NeuroscienceBiochemistry, Genetics and Molecular Biology
New England Journal of MedicinePsychotropic Drug Use and the Risk of Hip Fracture
1,005 Citations1987Wayne A. Ray, Marie R. Griffin +3 more
The hypothesis that the sedative and autonomic effects of psychotropic drugs increase the risk of falling and fractures in elderly persons is supported and the need for studies of this association in other populations is suggested.
The American Journal of MedicineScientific versus commercial sources of influence on the prescribing behavior of physicians
570 Citations1982Jerry Avorn, Milton Chen +1 more
To study the relative contributions of scientific and commercial sources of information, two index drugs were chosen, whose pharmacologic effects have been shown by controlled studies to be minimal or not significantly different from those of nonprescription (over-thecounter) preparations, but which are heavily advertised as being effective.
American Journal of EpidemiologyPsychoactive Drugs and the Risk of Injurious Motor Vehicle Crashes in Elderly Drivers
418 Citations1992Wayne A. Ray, Randy L. Fought +1 more
Analysis of data for the crash-involved drivers suggested that these findings were not due to confounding by alcohol use or driving frequency, and the relative risk of injurious crash involvement for current users of any psychoactive drug was 1.5.
BMJSelective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
401 Citations1993Fujian Song, Nick Freemantle +5 more
Routine use of selective serotonin reuptake inhibitors as the first line treatment of depressive illness may greatly increase cost with only questionable benefit, according to meta-analysis of 63 randomised controlled trials.
BMJFluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
363 Citations1991Charles M. Beasley, Bruce E. Dornseif +7 more
Data from these trials do not show that fluoxetine is associated with an increased risk of suicidal acts or emergence of substantial suicidal thoughts among depressed patients.
International Clinical PsychopharmacologySelective serotonin reuptake inhibitors
256 Citations1994S.A. Montgomery, J.A. Henry +6 more
There is a significant and clinically important advantage for the SSRIs compared with the TCAs in the acceptability of treatment measured by the number of discontinuations due to side effects reported in published studies.
BMJFatal toxicity of antidepressant drugs in overdose.
251 Citations1987S.L. Cassidy, John A. Henry
Of these newer drugs, maprotiline had a fatal toxicity index similar to that of the older tricyclic antidepressants, while the other newly introduced drugs had lower toxicity indices, with those for mianserin, nomifensine, trazodone, and viloxazine reaching significance.
Alcohol and AlcoholismTHE EFFECTS OF ALCOHOL AND OTHER DRUGS ON PSYCHOMOTOR PERFORMANCE AND COGNITIVE FUNCTION
205 Citations1991I. Hindmarch, John S. Kerr +1 more
The behavioural toxicity of alcohol is compared with the effects of these other drugs on psychomotor performance and cognitive function and the results are compared with those of a number of similar studies which examined theeffects of other psychoactive substances.
DrugsAntidepressants
192 Citations1989Matthew V. Rudorfer, William Z. Potter
A number of recent additions to this group of antidepressant medications, such as bupropion and ademetionine, incorporate novel mechanisms of action, challenging previous concepts of how antidepressants work, and offering opportunities for research into the pathophysiology of mood disorders.
International Clinical PsychopharmacologyThe costs of depression
136 Citations1993Paul Kind, Jan Sørensen
Estimates of the direct costs associated with the treatment of patients in England and Wales amount to some £420 million annually, and pharmaceutical costs represent a relatively small proportion of this total.
BMJUse of antidepressants among people committing suicide in Sweden
136 Citations1994G Isaccsson, P Holmgren +2 more
The current data suggest that most depressed patients who commit suicide are not taking antidepressants immediately before death, and therapeutic failure may be a greater problem with antidepressants than toxicity as the results did not indicate any advantage of the newer, less toxic antidepressants.
Journal of Affective DisordersComparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression
135 Citations1993Ellen Frank, David J. Kupfer +6 more
A small randomized clinical trial in which patients were assigned to either full-dose or half-dose maintenance treatment for a period of 3 years concludes that for patients who have suffered several recurrences, full- dose maintenance treatment is the more effective prophylactic strategy.
BMJPrescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide
100 Citations1994Nick Freemantle, Allan House +3 more
The cost per life year gained through avoiding suicides by the routine first line use of serotonin reuptake inhibitors is likely to be high and the shift to considerably more expensive options must be further investigated.
PubMed[Recurrence of unipolar depression and efficacy of maprotiline].
81 Citations1990F. Rouillon, Rachel Phillips +3 more
A vast multicenter study, including 1,141 patients suffering from depression and treated with maprotiline, double-blind versus placebo, in ambulatory, for 1 year, finding the tolerance of map rotiline was satisfactory with prolonged prescription and the difference being statistically significant between the 4 groups except for the "placebo" groups between them.
Human Psychopharmacology Clinical and ExperimentalThe prescribing of antidepressants in general practice. II: A placebo‐controlled trial of low‐dose dothiepin
53 Citations1989Christopher M. Thompson, Christopher M. Thompson
It is demonstrated that there is no advantage over placebo in the prescription of this dose of dothiepin, and on measures of depression and somatic symptoms placebo had a significant advantage in the group who completed the trial.
Acta Psychiatrica ScandinavicaA double blind comparison of lofepramine, imipramine and placebo in patients with primary depression
26 Citations1982John P. Feighner, C. H. Meridith +2 more
The results of double blind trial in which 139 patients with primary depression were randomly assigned to either lofepramine, imipramine or placebo are discussed and a statistically significant lower number of severe and/or moderate side effects were reported.
JAMASmoke and Letters
20 Citations1993Drummond Rennie
I relish such letters because they so often point to issues that neither the authors nor the reviewers and editors had ever imagined, which is the best and most lasting form of peer review.
Human Psychopharmacology Clinical and ExperimentalIs viloxazine an antidepressant? A placebo‐controlled double‐blind study in major depressive disorder presenting in a general hospital
14 Citations1991Christopher M. Thompson, G. Isaacs
The placebo‐treated group showed a slightly, but not significantly, greater improvement in depression scores using observer and self‐rating scales over those using viloxazine, which offers little support to its use as an antidepressant.